We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Store
» Commercial Operations
Search the Store
Shop By Category
Drug Products
Drug Books
Device Products
Device Books
Clinical Products
Shop By Media
Books
Webinar Recordings
Commercial Operations
-- Sort By --
New Arrivals
Best Sellers
Price: Low to High
Price: High to Low
A to Z
Democratic Presidential Hopefuls Offer Plans to Curb Rx Drug Costs
Price:
$40.00
Learn More
GPhA Challenges FDA Final Guidance on Pill Shape, Size
Price:
$40.00
Learn More
Allergan Reaches Settlement With Amneal Over Namenda XR ANDA
Price:
$40.00
Learn More
Impax Resolves Concerns in 2011 FDA Warning Letter
Price:
$40.00
Learn More
Concordia Boosts Generics With Amdipharm Acquisition
Price:
$40.00
Learn More
Sandoz Launches Zarxio, Sets Price At 15 Percent Below Neupogen
Price:
$40.00
Learn More
Managing Product Pipeline Communications
Price:
$397.00
Learn More
Drug Industry Slams French Law Promoting Off-Label Use
Price:
$40.00
Learn More
U.S. Industry Seeks Clarity on CMC Draft Guidance
Price:
$40.00
Learn More
Drugmakers Seek Clarity on FDA’s CMC Draft Guidance
Price:
$40.00
Learn More
Strategies for Biosimilars Approval: A Map to 351(k) Success
Price:
$397.00
Learn More
Pfizer Acquires Marketing Rights to Potential Copaxone Generic
Price:
$40.00
Learn More
Previous
1
2
…
13
14
15
16
17
18
19
20
21
…
27
28
Next